-
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu
2026-04-30
Explore how MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) advances the measurement of cellular metabolic activity and viability in complex biomedical contexts. This article uniquely bridges the latest insights from nanotechnology-driven cancer research with rigorous guidance for MTT assay optimization.
-
FerroOrange Fe²⁺ Probe: Advancing Live-Cell Iron Detection a
2026-04-30
Explore the unique advantages of FerroOrange, a Fe²⁺ fluorescent probe, for real-time intracellular iron detection in live cells. This in-depth article reveals advanced assay strategies and translational insights for neuroprotection research—unlocking new frontiers beyond standard protocols.
-
Targeting Glutamine Metabolism in HSCs to Alleviate Liver Fi
2026-04-29
This study demonstrates that modulating glutamine metabolism in hepatic stellate cells (HSCs), specifically by regulating SIRT4 and glutamate dehydrogenase (GDH) activity, can significantly reduce liver fibrosis. The findings highlight the potential for metabolic pathway targeting as an antifibrotic therapeutic approach and provide a mechanistic framework for future translational research.
-
Cell Cycle Assay Kit: Precision Analysis for G0/G1, S, G2/M
2026-04-29
The Cell Cycle Assay Kit (K2263) by APExBIO enables high-resolution analysis of cell cycle phases and apoptosis with streamlined PI/RNase A-based flow cytometry. Designed for cancer research and cell proliferation studies, its robust workflow delivers reproducible results and actionable insights for translational applications.
-
Sodium-Induced Mitochondrial Disruption Drives NECSO Cell De
2026-04-28
Qiao et al. reveal that sodium influx through TRPM4 channels disrupts mitochondrial energy metabolism, triggering necrosis by sodium overload (NECSO). Their mechanistic insights clarify how mitochondrial Na+ accumulation suppresses oxidative phosphorylation, informing future studies on cell death and energy failure in disease.
-
HSD17B12 Regulates PD-L1 Degradation to Boost Anti-Tumor Imm
2026-04-28
This study establishes HSD17B12 as a regulator of PD-L1 degradation via lysosomal pathways, enhancing anti-tumor immune responses in mice. Mechanistic insights suggest that targeting HSD17B12 could inform novel immunotherapy strategies for cancer.
-
AO/PI Double Staining Kit: Practical Guide for Cell Viabilit
2026-04-27
The AO/PI Double Staining Kit addresses the need for rapid, reliable discrimination of viable, apoptotic, and necrotic cells in cultured samples. Suitable for fluorescence-based cell viability, apoptosis, and necrosis detection, it is best applied in contexts where clear, single-assay differentiation of cell states is required. Use is not recommended for tissue sections or applications lacking fluorescence imaging capability.
-
EdU Imaging Kits (HF594): Powering Precision in Translationa
2026-04-27
This article unpacks the mechanistic advances and translational impact of EdU Imaging Kits (HF594) in modern immunology, spotlighting their role in enabling rigorous, artifact-free cell proliferation assays for Treg cell research and asthma pathophysiology. Integrating primary literature on SIRT3-SUMO–regulated Treg differentiation and clinical asthma models, it offers actionable guidance for researchers seeking to bridge bench insights with clinical relevance, and positions APExBIO’s EdU Imaging Kits as a next-generation tool for reproducible, high-sensitivity DNA synthesis measurement.
-
Caffeine (1,3,7-trimethylpurine-2,6-dione) Lab Protocol Guid
2026-04-26
Caffeine (SKU N2379) is a purine alkaloid used for in vitro and in vivo studies involving cancer cell line inhibition, energy metabolism modulation, and obesity research. It is optimized for water or DMSO solubilization and not recommended for protocols requiring ethanol solubility or long-term storage of solutions. Adhering to product specifications ensures reliable and reproducible results.
-
Cell Counting Kit-8 (CCK-8) Plus: Practical Assay Guidance
2026-04-25
Cell Counting Kit-8 (CCK-8) Plus addresses quantitative cell viability and cytotoxicity measurement in a rapid, sensitive format for proliferation and drug screening workflows. It is best suited for researchers requiring reliable, colorimetric quantification of living cells, but should not be used for non-metabolic or non-adherent cell viability scenarios without careful protocol adjustment.
-
Applied Workflows Using Cell Counting Kit-8 (CCK-8) for Viab
2026-04-24
Leverage the Cell Counting Kit-8 (CCK-8) for sensitive, reproducible cell viability and proliferation data in cancer research and drug discovery. This article details stepwise workflows, protocol enhancements, and troubleshooting strategies anchored in recent literature, empowering labs to achieve high-confidence results with minimal hands-on time.
-
NIR-Triggered Co-Single-Atom Enzyme for Multimodal Photother
2026-04-24
This study introduces a near-infrared (NIR)-responsive cobalt single-atom enzyme (Co-SAE) anchored on hollow N-doped carbon spheres, enabling on-demand activation of multimodal phototherapy for head and neck cancer. By synergistically amplifying highly reactive oxygen species (hROS) and mild hyperthermia within the tumor microenvironment, the approach overcomes the limitations of monomodal phototherapies and preserves critical tissue functions.
-
DAPI (Hydrochloride): Strategic DNA Visualization for Transl
2026-04-23
This thought-leadership article unlocks the mechanistic nuance and strategic deployment of DAPI (hydrochloride) for translational research. Bridging robust minor groove DNA binding with contemporary demands for quantitative, multiplexed cellular analysis, it provides actionable guidance for cell cycle and immuno-oncology workflows. Integrating evidence from immunomodulatory advances and competitive benchmarking, the article uniquely positions DAPI (hydrochloride) as a linchpin technology for next-generation translational applications.
-
ACSL1 Modulates Pulmonary Fibrosis via Mitophagy Enhancement
2026-04-23
This study demonstrates that ACSL1 alleviates pulmonary fibrosis by reducing mitochondrial damage and activating PINK1/Parkin-mediated mitophagy. These findings identify ACSL1 as a potential therapeutic target and provide mechanistic insight into mitochondrial quality control in fibrotic lung disease.
-
FBXO22 Ligand Discovery: New Degraders & 2-PCA for TPD Expan
2026-04-22
This study presents the identification of novel small-molecule degraders and the electrophilic ligand 2-pyridinecarboxaldehyde (2-PCA) for selective targeting of the E3 ligase FBXO22. The work advances targeted protein degradation (TPD) strategies by expanding the toolbox of E3 ligase recruiters, with implications for broadening the therapeutic potential of TPD beyond traditional ligases.